FDA authorizes Pfizer booster dose for 12 to 17 year-olds | CIDRAP

FDA authorizes Pfizer booster dose for 12 to 17 year-olds | CIDRAP: In other COVID developments, federal officials cleared two more rapid tests for emergency use as the weekly case average soared higher.